Search

everythinglearnresearchcommunity

for

Search:↓

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.

The conclusion is that recognizing the difference between gender identity and biological sex is crucial in dermatology to improve patient care and research accuracy.

Care for gender-dysphoric Veterans can be improved with a consistent, team-based approach.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Transgender and gender diverse youth often have skin issues like acne and scarring, but few get referred to dermatologists.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Forehead modification greatly increases the perception of femininity and is a safe procedure.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Transmasculine individuals on testosterone therapy need tailored contraception and fertility advice due to unique risks and benefits of each contraceptive method.

The healthcare for transgender veterans could be better with a more unified team approach.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Bicalutamide may help treat female pattern hair loss.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

Accurate gender and sex assessment in dermatology is essential for respectful and precise patient care.

Collecting sexual orientation and gender identity data in dermatology can lead to better, more sensitive care for sexual and gender minority patients.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Adults with gender dysphoria on hormone treatment often have skin problems like acne, which are common but not always recognized.

The document concludes that careful planning and execution of facial gender affirmation surgery after at least 12 months of hormonal therapy can improve the quality of life for transgender individuals.

Estrogen alone can lower testosterone in some transfeminine people.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Healthcare providers need better education and policies to serve transgender individuals effectively.

More research is needed to improve lower body gender affirmation techniques.